These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6869315)

  • 1. Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Ehrlich CE; Conroy J; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):427-30. PubMed ID: 6869315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study.
    Thigpen JT; Ehrlich CE; Creasman WT; Curry S; Blessing JA
    Am J Clin Oncol; 1983 Jun; 6(3):273-5. PubMed ID: 6846245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing J; Homesley HD; Adcock LL
    Am J Clin Oncol; 1983 Aug; 6(4):423-6. PubMed ID: 6688150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
    Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Bonomi P; Blessing J; Ball H; Hanjani P; DiSaia PJ
    Gynecol Oncol; 1989 Sep; 34(3):357-9. PubMed ID: 2767528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of maytansine in patients with advanced head and neck cancer.
    Creagan ET; Fleming TR; Edmonson JH; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2061-2. PubMed ID: 526939
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Sutton GP; Bundy B; Hatch KD
    Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
    Conroy JF; Lewis GC; Blessing JA; Mangan C; Hatch K; Wilbanks G
    Am J Clin Oncol; 1984 Apr; 7(2):131-3. PubMed ID: 6702716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical trials of maytansine, an antitumor plant alkaloid.
    Chabner BA; Levine AS; Johnson BL; Young RC
    Cancer Treat Rep; 1978 Mar; 62(3):429-33. PubMed ID: 348311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
    Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
    Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of maytansine using a 3-day schedule.
    Cabanillas F; Rodriguez V; Hall SW; Burgess MA; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1978 Mar; 62(3):425-8. PubMed ID: 348310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD; Hanjani P
    Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barrett RJ; Gallup DG
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.